The Hydroxychloroquine Scandal

Posted on 21st June, 2020


The following extracts are from the article "The Hydroxychloroquine Scandal" (18 JUN 20 PDF): 

"... It seems the [World Health Organisation] WHO, [the UK Medicines & Healthcare products Regulatory Agency] MHRA, [the French] Inserm, and public health bodies around the world have used fake science, fake data, deliberately destructive studies and what appears to be wilful ignorance to make sure hydroxychloroquine is never trialled as a preventative COVID-19 treatment.


... The Indian Council of Medical Research (ICMR) has stated that it will continue to advocate the use of hydroxychloroquine for front line health workers as no notable adverse reactions were evident. Dr Samiran Panda, director of the ICMR-National AIDS Research Institute, reported the results of Indian trials into it use as a prophylactic treatment for health professionals:

The main conclusion that can be drawn after analysing the data is that hydroxychloroquine has beneficial effects in infection risk reduction from fourth dose onwards…….[hydoxychloroquine] will help cut the risk of infection by 80% in healthcare workers who are not already sick."


Other Extracts:


"... the UK government were quick to invest in vaccine development. In their Coronavirus Action Plan, published on 3 March, the focus was overwhelmingly on vaccines. The Action Plan noted that a vaccine may not prevent infection from SARS-Cov-2 but could rather manage symptoms of the potentially resultant syndrome COVID-19: Given that there is currently neither a vaccine against COVID-19 nor any specific, proven, antiviral medication, most treatment will therefore be towards managing symptoms … innovate responses including diagnostics, drugs and vaccines"


"... As Johnson's comments reveal, there is much more than just healthcare riding on the back of Coronavirus vaccine development. The vaccine itself sits at the centre of a web of surveillance, restricted freedom of movement and restricted access to employment and services based upon your allocated immunity status ... A whole new tech industry, combining global corporations and intelligence agencies, is springing up to monitor, control and surveil populations"


"... Since at the time of writing, COVID-19 is said to have impacted 0.1% of the global population, allegedly killing less than 0.006%, the WHO's measure of success for a global vaccine being that it protect 70% of the global population from a disease that doesn't affect 99.9% of the population, the chances of WHO approval for anything look pretty good - an inert saline solution should do the job. It is not surprising, then, that vaccine developers are so confidently looking forward to a global market and global profits."


"... A cheap, widely available off patent drug that achieves exactly the same thing as the vaccine must, therefore, be seen as a problem. [e.g. Hydroxycholoroquine] ... The persistent claim, repeated ad nauseam by the mainstream media, that hydroxychloroquine presents some sort of severe heart risk, simply isn't true ... There is virtually no cardiovascular risk at all to taking it, as recommended, for short course treatments. As you would if you took it as a prophylaxis for COVID-19."


"... for more than 50 years, the French had been able to buy hydroxychloroquine over the counter. Once demand shot through the roof, as the COVID-19 crisis unfolded, they suddenly could no longer get it without a prescription."


"...on 22 May the Lancet published a study by a team of four U.S. researchers ... authors of the study requested that the Lancet withdraw the paper, which it did on 3 June ... Yet, despite the fact that scientists from across the globe were able to spot the fake paper with ease, neither the Lancet, nor the world’s leading experts in public health, the World Health Organisation, could ... Like the WHO, the [UK] MHRA either didn't exercise any due diligence or don't care about saving lives."


"... A number of other studies have not been able to find any significant benefit from remdisivir. The WHO withdrew some of these unfavourable remdesivir studies from their trial database as they had accidentally uploaded them. Other remdisivir trials were stopped when adverse effects were observed."


"... The recommended hydroxychloroquine dose for an adult in the UK is no more than 200 - 400mg per day. In France 1800mg per day is considered to be lethal poisoning ... Across 175 UK hospitals, 1542 patient participants in the Recovery Trials were given 2400mg (six times the recommended maximum dose) in the first twenty-four hours. This was followed up by ten days at twice the recommended maximum dose at 800mg"


"... It isn't really clear what the objective was. This wasn't so much a trial of effectiveness, it looked more like an experiment in toxic poisoning. It would seem to account for the atrocious mortality rate."



More info on BOB's COVID page


Make A Comment

Characters left: 2000

Comments (0)